Law360 reported, “Excess Insurer Owes Pfizer Coverage for Securities MDL’

On September 28, Delaware Superior Court Judge Paul R. Wallace ruled that Pfizer is entitled to coverage under its directors and officers policy with U.S. Specialty. The insurer will cover the “costs to defend and settle multidistrict litigation that accused the company of misleading investors about the alleged cardiovascular risks of its pain treatments Celebrex and Bextra.” Pfizer is represented by  Robin Cohen and Adam Ziffer. For more details, read the entire article here.